Hypogammaglobulinemia following non-myeloablative allogeneic stem cell transplant correlates with chimerism.

被引：0
|
作者：
Bolwell, BJ [1 ]
Pohlman, B [1 ]
Sobecks, R [1 ]
Andresen, S [1 ]
Rybicki, L [1 ]
Kuczkowski, E [1 ]
Jarvis, J [1 ]
Koennecke, J [1 ]
Bernhard, L [1 ]
Ostendorf, H [1 ]
Bell, K [1 ]
Serafino, S [1 ]
Theil, K [1 ]
Kalaycio, M [1 ]
机构：
[1] Cleveland Clin Fdn, Cleveland, OH 44195 USA
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5183
引用
收藏
页码：353B / 353B
页数：1
相关论文
共 50 条
  • [41] Chimerism analysis in peripheral blood buffy coat and T-cell fractions after non-myeloablative allogeneic peripheral blood stem cell transplant (PBSCT).
    Theil, K
    Warshawsky, I
    Tubbs, R
    Shadrach, B
    Serafino, S
    Cerankosky, L
    Johnston, G
    Rybicki, L
    Kuczkowski, E
    Jarvis, J
    Curtis, J
    Serafin, M
    Sands, K
    Bolwell, BJ
    BLOOD, 2001, 98 (11) : 188A - 189A
  • [42] Non-myeloablative allogeneic stem cell transplantation for metastatic renal cell carcinoma
    Bahnson, R
    Hu, HS
    Vogelzang, NJ
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2003, 21 (01) : 79 - 81
  • [43] Low rates of chimerism occur when alemtuzumab is added to conditioning therapy for non-myeloablative allogeneic stem cell transplantation
    Kasner, M.
    Loren, A.
    Stein, S.
    Goldstein, S.
    Luger, S.
    Nasta, S.
    Perl, A.
    Schuster, S.
    Tsai, D.
    Andreadis, B.
    Smith, J.
    Cole, S.
    Hinkle, J.
    Pillai, P.
    Emerson, S.
    Stadtmauer, E.
    Porter, D.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 92 - 92
  • [44] Early and late gastrointestinal complications after allogeneic stem cell transplantation following myeloablative and non-myeloablative conditioning.
    Schulenburg, A
    Turetschek, K
    Wrba, F
    Vogelsang, H
    Greinix, HT
    Keil, F
    Mitterbauer, M
    Kalhs, P
    BLOOD, 2002, 100 (11) : 631A - 631A
  • [45] Transient anti rhesus alloantibody produced by graft after non-myeloablative allogeneic stem cell transplant
    Contentin, N
    Lenain, P
    Chamouni, P
    Hau, F
    Bastit, D
    Buchonnet, G
    Tilly, H
    TRANSFUSION AND APHERESIS SCIENCE, 2004, 31 (03) : 191 - 197
  • [46] Analysis of phenotype, function, and chimerism of monocyte-derived dendritic cells after myeloablative vs non-myeloablative allogeneic stem cell transplantation
    Nachbaur, D
    Kircher, B
    Eisendle, K
    Laetzer, K
    Haun, M
    Gruenewald, K
    Gastl, G
    BONE MARROW TRANSPLANTATION, 2003, 31 : S198 - S199
  • [47] Non-Myeloablative Stem Cell Transplantation
    Robert Marcus
    Bone Marrow Transplantation, 2001, 27 (6) : 667 - 667
  • [48] Non-myeloablative stem cell transplant: A dose-finding study
    Bron, D
    Zachee, P
    Maertens, J
    Doyen, C
    Van den Berghe, P
    Ferrant, A
    Noens, L
    Schroyens, W
    Selleslag, D
    Demuynck, H
    Triffet, A
    De Meuter, A
    Boogaerts, M
    BLOOD, 2002, 100 (11) : 398B - 398B
  • [49] Non-myeloablative stem cell transplants
    Barrett, J
    Childs, R
    BRITISH JOURNAL OF HAEMATOLOGY, 2000, 111 (01) : 6 - 17
  • [50] LANGERHANS CELL CHIMERISM AFTER MYELOABLATIVE VERSUS NON-MYELOABLATIVE HEMATOPOIETIC CELL TRANSPLANTATION
    Kirkorian, Y.
    Collin, M.
    Leboeuf, M.
    Bogunovic, M.
    Wood, B.
    Hackman, R. C.
    Storer, B.
    Storb, R.
    Merad, M.
    Mielcarek, M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 8 - 8
12345